Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4504 | 1700 | 44.7 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NKG2D | Author keyword | 194 | 60% | 12% | 210 |
2 | NKG2D LIGANDS | Author keyword | 74 | 84% | 2% | 41 |
3 | MICB | Author keyword | 54 | 72% | 3% | 43 |
4 | MICA | Author keyword | 31 | 17% | 9% | 161 |
5 | ULBP | Author keyword | 30 | 68% | 2% | 27 |
6 | MICA B | Author keyword | 27 | 74% | 1% | 20 |
7 | MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN RELATED GENE A | Author keyword | 21 | 85% | 1% | 11 |
8 | SOLUBLE MICA | Author keyword | 20 | 100% | 1% | 9 |
9 | NKG2D LIGAND | Author keyword | 17 | 68% | 1% | 15 |
10 | MICA GENE | Author keyword | 11 | 65% | 1% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NKG2D | 194 | 60% | 12% | 210 | Search NKG2D | Search NKG2D |
2 | NKG2D LIGANDS | 74 | 84% | 2% | 41 | Search NKG2D+LIGANDS | Search NKG2D+LIGANDS |
3 | MICB | 54 | 72% | 3% | 43 | Search MICB | Search MICB |
4 | MICA | 31 | 17% | 9% | 161 | Search MICA | Search MICA |
5 | ULBP | 30 | 68% | 2% | 27 | Search ULBP | Search ULBP |
6 | MICA B | 27 | 74% | 1% | 20 | Search MICA+B | Search MICA+B |
7 | MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN RELATED GENE A | 21 | 85% | 1% | 11 | Search MAJOR+HISTOCOMPATIBILITY+COMPLEX+CLASS+I+CHAIN+RELATED+GENE+A | Search MAJOR+HISTOCOMPATIBILITY+COMPLEX+CLASS+I+CHAIN+RELATED+GENE+A |
8 | SOLUBLE MICA | 20 | 100% | 1% | 9 | Search SOLUBLE+MICA | Search SOLUBLE+MICA |
9 | NKG2D LIGAND | 17 | 68% | 1% | 15 | Search NKG2D+LIGAND | Search NKG2D+LIGAND |
10 | MICA GENE | 11 | 65% | 1% | 11 | Search MICA+GENE | Search MICA+GENE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | I RELATED CHAIN | 138 | 80% | 5% | 85 |
2 | NKG2D | 118 | 46% | 11% | 190 |
3 | NKG2D RECEPTOR | 80 | 43% | 8% | 141 |
4 | NKG2D LIGANDS | 75 | 62% | 5% | 77 |
5 | MIC LIGANDS | 73 | 86% | 2% | 37 |
6 | NKG2D LIGAND EXPRESSION | 54 | 80% | 2% | 33 |
7 | CHAIN RELATED GENE | 48 | 72% | 2% | 38 |
8 | GLYCOPROTEIN UL16 | 44 | 61% | 3% | 47 |
9 | TRIPLET REPEAT POLYMORPHISM | 44 | 60% | 3% | 48 |
10 | LINE NK 92 | 42 | 76% | 2% | 29 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Regulation of Ligands for the NKG2D Activating Receptor | 2013 | 110 | 138 | 64% |
Effect of NKG2D ligand expression on host immune responses | 2010 | 190 | 140 | 74% |
Natural killer cells for cancer immunotherapy: pluripotent stem cells-derived NK cells as an immunotherapeutic perspective | 2015 | 8 | 126 | 40% |
NKG2D signaling in cancer immunosurveillance | 2015 | 4 | 149 | 70% |
Roles of the NKG2D immunoreceptor and its ligands | 2003 | 686 | 74 | 69% |
NKG2D ligands in tumor immunity: two sides of a coin | 2015 | 3 | 83 | 80% |
Up on the tightrope: natural killer cell activation and inhibition | 2008 | 496 | 78 | 28% |
Molecular bases for the regulation of NIKG2D ligands in cancer | 2014 | 7 | 78 | 91% |
Activating natural cytotoxicity receptors of natural killer cells in cancer and infection | 2013 | 33 | 104 | 62% |
Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications | 2013 | 23 | 94 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INVEST BIOMED HOG | 4 | 75% | 0.2% | 3 |
2 | ECCELLENZA RIC BIOMED | 4 | 15% | 1.5% | 25 |
3 | IMMUNOPHARMACOL IMMUNOTHER Y | 4 | 19% | 1.0% | 17 |
4 | BASEL STEM CELL TRANSPLANT TEAM | 3 | 57% | 0.2% | 4 |
5 | UNIDAD HISTOCOMPATIBILIDAD TRANSPLANTES | 3 | 100% | 0.2% | 3 |
6 | INNATE IMMUN GRP | 3 | 28% | 0.5% | 8 |
7 | SECT BONE MARROW TRANSPLANT CELL THER Y | 3 | 30% | 0.4% | 7 |
8 | BIOL STRUTTURALE | 2 | 67% | 0.1% | 2 |
9 | SECT BONE MARROW TRANSPLANTAT CELL THER Y | 2 | 67% | 0.1% | 2 |
10 | GMP DEV UNIT | 2 | 50% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000270356 | ECCELLENZA RIC BIOMED//NKG2C//NK CELL MATURATION |
2 | 0.0000207645 | KIR//LY49//KILLER CELL IMMUNOGLOBULIN LIKE RECEPTORS |
3 | 0.0000122650 | MOL IMMUNOL RUMENTAT//GENOMIC MATCHING TECHNIQUE//HLA A ALLELES |
4 | 0.0000120917 | CYTOKINE INDUCED KILLER CELLS//CIK CELLS//CYTOKINE INDUCED KILLER CELL |
5 | 0.0000081749 | MHC NONRESTRICTED CYTOTOXICITY//HISTAMINE DIHYDROCHLORIDE//BOWYER ONCOL |
6 | 0.0000072652 | NECTIN//TSLC1//AFADIN |
7 | 0.0000068456 | XLP//2B4//X LINKED LYMPHOPROLIFERATIVE DISEASE |
8 | 0.0000062402 | MURINE CYTOMEGALOVIRUS//MCMV//LY49H |
9 | 0.0000056588 | INTERLEUKIN 15//IL 15//IL 15R ALPHA |
10 | 0.0000052584 | GAMMA DELTA T CELLS//GAMMA DELTA T CELL//PHOSPHOANTIGEN |